Frankfurt
29.01.25
21:48 Uhr
0,334 Euro
+0,004
+1,21 %
+1,21 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.01. | Benchmark Holdings plc: Financial calendar | 2 | Oslo Børs | ||
| 08.01. | Benchmark Holdings plc: Provision of Annual Report | 1 | Oslo Børs | ||
| 07.01. | Benchmark Holdings plc: Publication of Annual Report | 1 | Oslo Børs | ||
| BENCHMARK HOLDINGS Aktie jetzt für 0€ handeln | |||||
| 07.01. | Benchmark Hlgs PLC - Publication of Annual Report | - | RNS | ||
| 06.01. | Benchmark Holdings plc: Financial calendar | - | Oslo Børs | ||
| 31.12.24 | Benchmark Holdings plc: Total Voting Rights | 2 | Oslo Børs | ||
| 31.12.24 | Benchmark Hlgs PLC - Total Voting Rights | - | RNS | ||
| 16.12.24 | Benchmark Holdings plc: Result of General Meeting to approve the Disposal of the Genetics Business | - | Oslo Børs | ||
| 16.12.24 | Benchmark Holdings divests genetics unit to Novo Holdings | 4 | Investing.com | ||
| 16.12.24 | Benchmark Hlgs PLC - Result of General Meeting | - | RNS | ||
| 12.12.24 | Benchmark Holdings annual loss widens; sets returns from Genetics sale | 2 | Alliance News | ||
| 12.12.24 | Benchmark Holdings plc: Chairman Appointment | 1 | Oslo Børs | ||
| 12.12.24 | Benchmark Holdings plc: Full Year Results for the Financial Year ended 30 September 2024 | 3 | Oslo Børs | ||
| 12.12.24 | Benchmark Holdings streamlines operations amid market challenges | 2 | Investing.com | ||
| 12.12.24 | Benchmark Hlgs PLC - Chairman Appointment | - | RNS | ||
| 12.12.24 | Benchmark Hlgs PLC - Q4 Results | - | RNS | ||
| 12.12.24 | Benchmark Hlgs PLC - Full Year Results | - | RNS | ||
| 10.12.24 | Benchmark Holdings plc: Notice of Q4 and Full Year Results; Presentation and webcast for analysts and institutional investors; Equity Development webcast for retail investors | - | Oslo Børs | ||
| 29.11.24 | Benchmark Holdings plc: Total Voting Rights | - | Oslo Børs | ||
| 29.11.24 | Benchmark Hlgs PLC - Total Voting Rights | - | RNS |
Seite:
1 2 3 Weiter >>
43 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 21,540 | +0,21 % | Bayer Aktie in Gefahr: Trendwende weiter wackelig | Die Bayer Aktie bleibt charttechnisch in einer kritischen Phase. Mit einem Kursverlust von über 2 Prozent auf XETRA im gestrigen Handel fiel der Aktienkurs zurück, ohne sich zuvor deutlich von den jüngst... ► Artikel lesen | |
| NOVO NORDISK | 80,91 | -0,09 % | Novo Nordisk Aktie: Verheißungsvoller Start ins neue Quartal! | Die Aktien des dänischen Pharmaunternehmens Novo Nordisk verzeichneten am Freitag einen beeindruckenden Kurssprung von fast 12 Prozent, nachdem vielversprechende Studienergebnisse zum neuen Abnehmmittel... ► Artikel lesen | |
| GSK | 16,850 | +0,90 % | Global Health Innovative Technology Fund (GHIT Fund): A Total of USD 12.7 Million Investment in New Diagnostics and Drug Development for NTDs and Malaria to Partners Including the Ohio State University, PATH, GSK and Others | TOKYO, Jan. 30, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 2 billion (USD 12.7 million1) in eight projects... ► Artikel lesen | |
| INNOCAN PHARMA | 0,110 | -1,35 % | Innocan-Tochter BI Sky Global schließt HRIPT-Tests ab und übertrifft wichtige Absatzmarke | Herzliya, Israel und Calgary, Alberta - 29. Januar 2025 / IRW-Press / Innocan Pharma Corporation (CSE:
INNO) (FWB: IP4) (OTCQB: INNPF) ("Innocan" oder das "Unternehmen"), ein Pionier in der Pharma-... ► Artikel lesen | |
| EYEPOINT PHARMACEUTICALS | 7,980 | +7,61 % | EyePoint Pharmaceuticals, Inc.: EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | WATERTOWN, Mass., Jan. 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients... ► Artikel lesen | |
| EDWARDS LIFESCIENCES | 68,75 | +0,61 % | Edwards Lifesciences-Aktie: Kurs legt zu (69,1716 €) | An der US-amerikanischen Börse notiert die Edwards Lifesciences-Aktie aktuell fester. Zuletzt zahlten Investoren für das Papier 72,11 US-Dollar. Jahreschart der Edwards Lifesciences Corp-Aktie, Stand... ► Artikel lesen | |
| WPD PHARMACEUTICALS | 0,112 | +0,09 % | CSE Bulletin: Consolidation - WPD Pharmaceuticals Inc. (WBIO) | le 23 décembre/December 2024
WPD Pharmaceuticals Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every twenty-five... ► Artikel lesen | |
| MYDECINE INNOVATIONS GROUP | 0,008 | 0,00 % | Mydecine Innovations Group Inc - Mydecine Announces Filing of Q3 Financial Statements | Mydecine Innovations Group Inc - Mydecine Announces Filing of Q3 Financial Statements
PR Newswire
LONDON, United Kingdom, November 21
MYDECINE ANNOUNCES FILING OF Q3 FINANCIAL... ► Artikel lesen | |
| HAPPY BELLY FOOD GROUP | 0,750 | -2,60 % | Happy Belly Food Group Inc.: Happy Belly Closes 100% Acquisition of Smile Tiger Coffee Roasters Inc | Toronto, Ontario--(Newsfile Corp. - January 27, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leading consolidator of emerging food brands is happy... ► Artikel lesen | |
| CHRISTINA LAKE CANNABIS | 0,018 | -14,29 % | Christina Lake Cannabis announces investment | ||
| PSYCHED WELLNESS | 0,011 | 0,00 % | Psyched Wellness Ltd.: Psyched Wellness Announces Appointment of New Director and Resignation of a Director | Toronto, Ontario--(Newsfile Corp. - November 25, 2024) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production... ► Artikel lesen | |
| JAZZ PHARMACEUTICALS | 118,05 | -1,05 % | Jazz Pharmaceuticals plc: Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference | DUBLIN, Dec. 17, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will webcast its corporate presentation at the 43rd Annual J.P. Morgan Healthcare... ► Artikel lesen | |
| DAIICHI SANKYO | 27,190 | -0,66 % | FDA Approves AstraZeneca And Daiichi Sankyo's ENHERTU For HER2-Low/Ultralow Breast Cancer | LONDON (dpa-AFX) - The U.S. Food and Drug Administration has approved AstraZeneca Plc. (AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK) ENHERTU (fam-trastuzumab deruxtecan-nxki) for the treatment... ► Artikel lesen | |
| SWEET EARTH | 0,137 | +2,24 % | Sweet Earth Holdings Corp (4): Sweet Earth closes $1.19-million private placement | ||
| H LUNDBECK | 5,700 | -0,61 % | H. Lundbeck A/S: Lundbeck announces FDA plans to host an Advisory Committee meeting on the sNDA for brexpiprazole in combination with sertraline for the treatment of adults with PTSD | H. Lundbeck A/S (Lundbeck) announces that the U.S. Food and Drug Administration (FDA) plans to host a Psychopharmacologic Drugs Advisory Committee (PDAC) meeting to seek input on issues related to the... ► Artikel lesen |
BENCHMARK HOLDINGS PLC gehört der Branche Pharma an. Der aktuelle Kurs liegt bei 0,334 Euro und damit +1,21 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BENCHMARK HOLDINGS PLC finden Sie auf Wallstreet Online.
